Login
Login     |     Register     |     Recover Username/Password

General Investing

Medical Real Estate Faces Low Cost of Capital, Fragmented Growth

August 17, 2012

Property owners in the medical real estate sector are benefiting from a low cost of capital, increased access to capital and a still-fragmented industry’s growth opportunities, says Daniel Bernstein, CFA, an Analyst at Stifel, Nicolaus & Co., Inc., however, he has been cautious on some of the valuations in the sector due to the macroeconomic environment.

“I think with the cost of capital decreasing, mainly because of the decrease in the 10-year Treasury, particularly for large portfolios of high-quality senior housing and medical office, we are continuing to see and expect further cap rate compression, perhaps 25 to 50 basis points of compression from the acquisition rates that we saw some of the large caps make last year,” he said. “The increasing real estate value is, I think, an indicator of potential for increased stock prices in the health care REIT sector.”

Bernstein has Sabra Health Care REIT, Inc. (SBRA) as his top pick on the health care REIT side. He says Sabra was created from the split of the property from the operator at Sun Healthcare in late 2010, and he likes SBRA despite some risk affiliated with the company due to about 70% of the NOI is with one tenant, currently Sun Healthcare.

“But as Sabra diversifies its tenant mix away from Sun, and also potentially later on, maybe a year or two out, begins to diversify away from postacute/skilled nursing and into senior housing, as their cost of capital comes down, we think there’s potential for Sabra’s multiple to increase from where it is today,” Bernstein said.


TSWT - Subscribe now!

The Wall Street Transcript is a completely unique resource for investors and business researchers.

Over 20,000 CEO, Equity Analyst and Money Manager Interviews

TWST Newsletter

Weekly email with New In-Depth Interviews

Most Popular Interviews
Opportunities in Hepatitis C and Genomic Technologies
David Ferreiro

Published April 26, 2014 in Biotechnology and Pharmaceuticals

Buy ($75)
Investing in Health Care Innovation
Finny Kuruvilla

"We’re a faith-based and socially responsible investing firm"

Published May 16, 2013 in Investing in Health Care

Buy ($75)
A Health Sciences Fund with a Long-Term Focus
Mark W. Oelschlager

"The fund is about $40 million in assets"

Published May 16, 2013 in Investing in Health Care

Buy ($75)
High-Yield Canadian Power Companies
John McIlveen

Published May 14, 2013 in High-Yield Equity Securities

Buy ($75)
Most Popular Reports
Investing in Health Care

Published May 16, 2013

Topics Covered: Health Care - Electronic Health Record Adoption - Biotechnology and Pharmaceutical Investing - Biotechnology and Pharmaceuticals - Biotechnology and Pharmaceutical Companies Valuation - Platform Interoperability and Data Analytics - HITECH Act Incentives - Affordable Care Act
Buy ($175)
Internet Services

Published May 10, 2013

Topics Covered: Increased Mobile Content Traffic - Chinese Online Monetization Trends - Internet Infrastructure and Services Consolidation - Social Networking Economics -
Buy ($175)
Investing Strategies

Published May 10, 2013

Topics Covered: Investing in Financial Services - Long-Term Investing - Large Cap Investing - Value Investing - High Quality Companies - Bottom-up Investing - All-Cap Growth Investing - Investing in Emerging Markets
Buy ($175)
Top Company Interviews
TWST
Register for a Free Account to gain greater access to The Wall Street Transcript right now